The Recall Desk
ModerateFDA (Drugs)·D-0092-2018·Announced 2017-11-29

Lupin Recalls Pravastatin Sodium Tablets Due to Foreign Capsule Presence

Lupin Limited is recalling specific lots of Pravastatin Sodium tablets because a foreign Duloxetine capsule was found in a bottle.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The recall is classified as FDA Class II. The hazard involves a foreign object (wrong medication) in the packaging, which is a significant quality issue but does not involve a high-risk pathogen or confirmed serious injury, fitting the Moderate category for low-risk contamination or labeling/packaging errors.

Plain-English summary

Lupin Limited is recalling Pravastatin Sodium USP, 40 mg tablets, 90-count bottles, NDC 68180-487-09. The recall is limited to Lot # G702459 with an expiration date of 2/20.

The recall was initiated due to a pharmacy complaint reporting that one Duloxetine Delayed Release Capsule, 30mg, was found inside a bottle of Pravastatin Sodium Tablets USP, 40mg. This constitutes a presence of foreign tablets/capsules.

The product was distributed throughout the United States, including Puerto Rico. Consumers should check their medication for the specific lot number and expiration date listed above. If the medication matches the recalled lot, consumers should stop using it and contact their pharmacist or healthcare provider for guidance.

The recalled product

Product
PRAVASTATIN SODIUM (PRAVASTATIN SODIUM)
Brand
PRAVASTATIN SODIUM
Manufacturer
Lupin Limited

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • Lot # G702459
  • Exp 2/20

UPCs (1)

  • 0368180487098

Distribution

Distributed in 1 state: